NCT05943106
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants treatment 3 recruiting NCT06630871
A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk. treatment 2 not_yet_recruiting NCT06588179
SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt No drug interventions treatment 1 / 2 not_yet_recruiting NCT05943379
RC48-ADC in Combination With Gemcitabine in High Risk NMIBC Subjects treatment 2 recruiting NCT05014139
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 recruiting NCT03914794
A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors treatment 2 recruiting NCT05375903
A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 recruiting NCT06181266
A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer No drug interventions treatment 1 recruiting NCT03038321
Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? treatment 4 unknown_status NCT06351904
A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy No drug interventions treatment 1 recruiting NCT06186414
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination With BCG in NMIBC No drug interventions treatment 1 recruiting NCT06637423
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) No drug interventions treatment 1 / 2 not_yet_recruiting NCT06632964
A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer No drug interventions treatment 1 recruiting NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer treatment 3 recruiting NCT06503614
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer treatment 2 not_yet_recruiting NCT01310803
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder treatment 3 terminated NCT05085990
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (Phase 1b) No drug interventions treatment 1 active_not_recruiting NCT04498702
Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy No drug interventions treatment 2 completed NCT03560479
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer No drug interventions treatment 1 / 2 unknown_status NCT04100733
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor No drug interventions diagnostic Not Available active_not_recruiting NCT05332353
Machine Learning-Based Prediction of BCG Response in High-Risk Non-Muscle Invasive Bladder Cancer Patients No drug interventions Not Available Not Available unknown_status NCT01458847
Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer No drug interventions treatment 1 completed NCT05327647
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer treatment 2 recruiting NCT06253845
Study of CG0070 After Transurethral Resection in Patients With IR NMIBC treatment 1 recruiting NCT05337397
Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available recruiting NCT02316171
CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON) treatment 1 completed NCT05672615
Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG No drug interventions Not Available Not Available recruiting NCT05996952
RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer No drug interventions treatment 2 not_yet_recruiting NCT06187506
Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer treatment 2 recruiting NCT04664816
Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer No drug interventions prevention Not Available unknown_status NCT04644835
Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer No drug interventions treatment Not Available unknown_status NCT05957757
RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression treatment 2 recruiting NCT04943094
Clinical and Functional Consequences of Photodynamic Diagnosis (PDD) and Intravesical Instillation Therapy No drug interventions Not Available Not Available active_not_recruiting NCT05223491
En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer No drug interventions diagnostic Not Available recruiting NCT06245603
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer No drug interventions treatment Not Available not_yet_recruiting NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer No drug interventions treatment 2 recruiting NCT04859751
Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer treatment 3 unknown_status NCT06235853
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT05085977
Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (Phase 1a) No drug interventions treatment 1 active_not_recruiting NCT04490993
Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients treatment 3 unknown_status NCT02969109
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT04375813
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention prevention 2 recruiting NCT04165317
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer treatment 3 active_not_recruiting NCT02138734
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer treatment 1 / 2 recruiting NCT06126796
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC) No drug interventions Not Available Not Available recruiting NCT03081858
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer treatment 1 / 2 completed NCT03933826
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer No drug interventions Not Available Not Available active_not_recruiting NCT06227065
Precise Neoadjuvant Chemoresection of Low Grade NMIBC treatment 2 not_yet_recruiting NCT05704231
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT01625260
A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer treatment 1 / 2 terminated NCT04736394
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients treatment 3 recruiting NCT03221062
"En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study No drug interventions treatment 4 unknown_status NCT06443944
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG Not Available Not Available available NCT05126472
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment No drug interventions treatment 1 recruiting NCT06241755
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) No drug interventions treatment 3 recruiting NCT02075060
Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer No drug interventions treatment 2 unknown_status NCT05544552
Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations No drug interventions treatment 1 / 2 recruiting NCT05519241
A Phase I Intravesical PPM Therapy for NMIBC treatment 1 recruiting NCT05962541
Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) treatment 4 not_yet_recruiting NCT05580354
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer treatment 4 not_yet_recruiting NCT06245759
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients No drug interventions Not Available Not Available recruiting NCT05796375
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance No drug interventions health_services_research Not Available recruiting NCT05864599
External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group No drug interventions Not Available Not Available active_not_recruiting NCT04690699
LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05232136
OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer treatment 1 / 2 recruiting NCT05547516
Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients treatment Not Available unknown_status NCT03664258
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) No drug interventions Not Available Not Available completed NCT05538663
Intravesical BCG vs GEMDOCE in NMIBC treatment 3 recruiting NCT05710848
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer No drug interventions treatment 1 / 2 recruiting NCT03528694
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer treatment 3 active_not_recruiting NCT03950362
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer treatment 2 unknown_status NCT05626101
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study treatment Not Available recruiting NCT05483868
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer treatment 1 recruiting NCT05825950
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC) No drug interventions Not Available Not Available recruiting NCT05002556
AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT06327932
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer prevention 3 not_yet_recruiting NCT05671900
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer treatment Not Available active_not_recruiting NCT05675176
Antegrade Observational Comparative Study for the Intravesical Instillation Therapy of Bacillus Calmette Guerin With the Use of Different Types of Urinary Catheters in Patients With Urinary Bladder Cancer No drug interventions Not Available Not Available completed NCT05790850
Pre-Habilitation With Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) No drug interventions supportive_care Not Available recruiting NCT05176145
Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test No drug interventions diagnostic Not Available recruiting NCT02009332
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer treatment 1 / 2 completed NCT03719300
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC treatment 2 terminated NCT04179162
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment treatment 1 / 2 recruiting NCT03839472
Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors No drug interventions treatment Not Available withdrawn NCT03167151
Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) treatment 1 / 2 terminated NCT06069453
Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC. No drug interventions treatment Not Available terminated NCT03148158
Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident No drug interventions Not Available Not Available unknown_status NCT03672240
Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment No drug interventions treatment 1 / 2 completed NCT06205277
Predictors of Residual Tumor at Second Transurethral Resection for pT1 Non-muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed NCT04387461
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin treatment 2 unknown_status NCT01004211
Prospective Randomized Comparison of Transurethral Resection by Mean of White Light and Narrow Band Imaging No drug interventions treatment Not Available completed NCT01731652
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer treatment 2 completed NCT01799499
A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) No drug interventions treatment Not Available withdrawn NCT03421236
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC) No drug interventions treatment 1 unknown_status NCT06287541
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection No drug interventions treatment Not Available recruiting NCT06111235
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT treatment 3 recruiting NCT04452591
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin No drug interventions treatment 3 recruiting NCT02982395
Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC treatment 3 terminated NCT02343614
Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer treatment 2 completed NCT06020807
Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer No drug interventions Not Available Not Available completed NCT06167356
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. No drug interventions Not Available Not Available recruiting NCT02895620
Effect on Xpert® Bladder Test of Urines Inflammatory Milieu Induced by BCG Treatment of Patients With NMIBC No drug interventions Not Available Not Available unknown_status NCT05981131
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC) Not Available Not Available active_not_recruiting NCT05945108
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER No drug interventions Not Available Not Available completed NCT00582387
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer No drug interventions Not Available Not Available completed